معرفی
Edward Gerstenfeld, MD, MS, is the Melvin Scheinman Endowed Professor of Medicine and Chief of the Section of Cardiac Electrophysiology at UCSF School of Medicine. He specializes in complex cardiac arrhythmias, including atrial fibrillation ablation, ventricular tachycardia management, and inherited arrhythmia syndromes. His clinical practice focuses on advanced electrophysiology procedures, such as catheter ablation and device therapy. Gerstenfeld holds editorial roles at multiple cardiology journals and contributed to the 2017 and 2024 HRS/EHRA ablation guidelines.
Education & Training:
- BSE in Biomedical/Electrical Engineering from Duke University (1988)
- M.D. and M.S. in Biomedical Engineering from Northwestern University (1993)
- Internal Medicine residency at Beth Israel Hospital (1996), Cardiology fellowship at University of Massachusetts (1999), and Cardiac Electrophysiology fellowship at University of Pennsylvania (2001).
Research Interests: His lab investigates atrial fibrillation mechanisms using signal processing and swine models of pacing-induced cardiomyopathy. Key areas include pulsed field ablation efficacy, ventricular tachycardia ablation techniques, and atrial remodeling from premature beats.
Publications: Over 200 peer-reviewed articles, with recent focus on pulsed field ablation outcomes (ADVANTAGE AF trial), coronary safety, and consensus guidelines. His work bridges clinical trials and preclinical models to advance arrhythmia treatments.
Labs/Teams: Leads UCSF's cardiac electrophysiology research team, collaborating on device innovation (e.g., HiFU ablation) and translational studies in arrhythmia pathophysiology.